nach oben

Journal of Cardiovascular Translational Research

Erschienen in:

01.06.2013

Synergistic Effect Between Lipoprotein Lipase and Apolipoprotein C3 Genes in Determining the Severity of Coronary Artery Disease

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

A number of genetic variants have been identified in the lipoprotein lipase (LPL) gene. We aimed to investigate the possible associations between LPL gene and apolipoprotein C3 (APOC3) gene polymorphisms with coronary artery disease (CAD) and its severity, as well as the interaction between these polymorphisms and classical risk factors. The HindIII variant of LPL and APOC3 were genotyped in 156 CAD patients and 154 subjects as a control group. We found that the odds ratio (OR) estimating the effect of joint exposure to H2H2 genotype of LPL and S2S2 genotype of APOC3 was significantly higher than the OR estimating the effect of each factor in the absence of the other. The present study points to a synergistic interaction between H2H2 genotype of LPL gene and S2S2 genotype of APOC3 gene that leads to increased severity of CAD. Smoking, low HDL, and diabetes increased the severity of CAD in patients carrying these risky genotypes.

Bainton, D., Miller, N. E., Bolton, C. H., Yarnell, J. W., Sweetnam, P. M., Baker, I. A., et al. (1992). Plasma triglycerides and high-density lipoprotein cholesterol as predictors of ischemic heart disease in British men: the Caerphill and Speedwell Collaborative Heart Disease Studies. British Heart Journal, 68, 60–66.PubMedCrossRef

Wittrup, H. H., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (1999). Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease: a meta-analysis. Circulation, 99, 2901–2907.PubMedCrossRef

Goldberg, I. J. (1996). Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. Journal of Lipid Research, 37, 693–707.PubMed

Newnham, H. H., & Barter, P. J. (1992). Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase. Biochimica et Biophysica Acta, 1125, 297–304.PubMedCrossRef

Clee, S. M., Bissada, N., Miao, F., Miao, L., Marais, A. D., Henderson, H. E., et al. (2000). Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. Journal of Lipid Research, 41, 521–531.PubMed

Murthy, V., Julien, P., & Gagne, C. (1996). Molecular pathobiology of the human lipoprotein lipase gene. Pharmacology and Therapeutics, 70, 101–135.PubMedCrossRef

Gotoda, T., Yamada, N., Murase, T., Shimano, H., Shimada, M., Harada, K., et al. (1992). Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion. Journal of Lipid Research, 33, 1067–1072.PubMed

Alaupovic, P. (1996). Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. Methods in Enzymology, 263, 32–60.PubMedCrossRef

McConathy, W. J., Gesquiere, J. C., Bass, H., Tartar, A., Fruchart, J. C., & Wang, C. S. (1992). Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. Journal of Lipid Research, 33, 995–1003.PubMed

10.

Hoffer, M. J. V., Sijbrands, E. J. G., De Man, F. H. A. F., Havekes, L. M., & Smelt, A. H. M. (1998). Increased risk of endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. European Journal of Clinical Investigation, 28, 807–812.PubMedCrossRef

11.

Kee, F., Amouyel, P., Fumeron, F., Arveiler, D., Cambou, J. P., Evans, A., et al. (1999). Lack of association between genetic variations of apo A-I-CIII-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis, 145, 187–195.PubMedCrossRef

12.

Freeman, D. J., Caslake, M. J., Griffin, B. A., Hinnie, J., Tan, C. E., Watson, T. D. G., et al. (1998). The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin: cholesterol acyl transferase activities in human plasma. European Journal of Clinical Investigation, 28, 584–591.PubMedCrossRef

13.

Walk, R., Berger, P., Lennon, R. J., Brilakis, E. S., Johnson, B. D., & Somers, V. K. (2004). Plasma leptin and prognosis in patients with established coronary atherosclerosis. Journal of the American College of Cardiology, 44, 1819–1824.CrossRef

14.

Vlietstra, R. E., Kronmal, R. A., Frye, R. L., Seth, A. K., Tristani, F. E., & Killip, T., 3rd. (1982). Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis, 2, 208–15.PubMedCrossRef

15.

Frieldewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499–502.

16.

Mattu, R. K., Needham, E. W. A., Morgan, R., Rees, A., Hackshaw, A. K., Stocks, J., et al. (1994). DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arteriosclerosis and Thrombosis, 14, 1090–1097.PubMedCrossRef

17.

Singh, P., Singh, M., Bhatnagar, D. P., Kaur, T., & Mastana, S. (2008). Apolipoprotein C3 (SstI) gene variability in Northwest India: a global perspective. International Journal of Human Genetics, 8, 51–60.

18.

Rothman, K. J. (1974). Synergy and antagonism in cause–effect relationship. American Journal of Epidemiology, 99, 385–388.PubMed

19.

Pasalic, D., Ferencak, G., Grskovic, B., Sesto, M., & StavljeniC-Rukavina, A. (2006). Association of two genetic variations of lipoprotein lipase, S447X and HindIII, with coronary artery disease and hypertriglyceridemia. Collegium Antropologicum, 30, 549–554.PubMed

20.

Ordovas, J. M., Civeira, F., Genest, J., Jr., Craig, S., Robbins, A. H., Meade, T., et al. (1991). Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationship with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis, 87, 75–86.PubMedCrossRef

21.

Russo, G. T., Meigs, J. B., Cupples, L. A., Demissie, S., Otvos, J. D., Wilson, P. W. F., et al. (2001). Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis, 158, 173–181.PubMedCrossRef

22.

Kawakami, A., Masanori, A., Libby, P., Alcaide, P., Luscinskas, F. W., & Sacks, F. M. (2006). Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation, 113, 691–700.PubMedCrossRef

23.

Bobik, A. (2008). Apolipoprotein CIII and atherosclerosis beyond effects on lipid metabolism. Circulation, 118, 702–704.PubMedCrossRef

24.

Abd El-Aziz, T. A., Mohamed, R. H., & Hashem, R. M. (2011). Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients. Molecular and Cellular Biochemistry, 354, 141–150.PubMedCrossRef

25.

Magill, P., Rao, S. N., Miller, N. E., Nicoll, A., Brunzell, J., Hilaire, J. S., et al. (1982). Relationships between the metabolism of high density and very low density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. European Journal of Clinical Investigation, 12, 113–120.PubMedCrossRef

26.

Araújo, L. M. Q., Cendoroglo, M. S., Gigek, C. O., Chen, E. S., & Smith, M. A. C. (2010). Association of lipase lipoprotein polymorphisms with high-density lipoprotein and triglycerides in elderly men. Genetics and Molecular Research, 9(1), 89–96.PubMed

Titel: Synergistic Effect Between Lipoprotein Lipase and Apolipoprotein C3 Genes in Determining the Severity of Coronary Artery Disease
Publikationsdatum: 01.06.2013
Erschienen in: Journal of Cardiovascular Translational Research / Ausgabe 3/2013
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-013-9446-3

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Clinical Impact of Genetically Determined Platelet Reactivity

Pharmaco-mechanic Antithrombotic Strategies to Reperfusion of the Infarct-Related Artery in Patients with ST-Elevation Acute Myocardial Infarctions

von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina

Beneficial Cardiac Effects of Caloric Restriction Are Lost with Age in a Murine Model of Obesity

St. John’s Wort in Patients Non-responders to Clopidogrel Undergoing Percutaneous Coronary Intervention: a Single-Center Randomized Open-Label Trial (St. John’s Trial)